Brief: Prime Medicine Inc Reports Quarterly Loss Per Share Of $0.44
11/05/2023 13:53
May 11 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATES
* CASH, CASH EQUIVALENTS, INVESTMENTS AND RESTRICTED CASH
BALANCE
OF $263.0 MILLION AS OF MARCH 31, 2023
* PRIME MEDICINE- EXPECTS CASH, CASH EQUIVALENTS,INVESTMENTS
TO BE
SUFFICIENT TO FUND ANTICIPATED OPERATING EXPENSES,CAPEX
REQUIREMENTS INTO 2025
* QTRLY LOSS PER SHARE $0.44
* Q1 EARNINGS PER SHARE VIEW $-0.42 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXk4N7V
Further company coverage: PRME.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease